[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.194.134. Please contact the publisher to request reinstatement.
Curated health policy research and original commentary from across the JAMA Network
health-forum_ChannelsBanner
[Skip to Content Landing]
Insights
Value and Payment Policy

Expanding the Quality Collaborative Model as a Blueprint for Higher-Value Care

  • 1Department of Surgery, University of Michigan, Ann Arbor
  • 2Center for Healthcare Outcomes and Policy, Ann Arbor, Michigan

The state of Michigan is home to the largest group of continuous quality improvement (CQI) collaboratives in the United States. In response to a charge from health care consumers and several large employers to improve the value of care, the state’s dominant private payer made the strategic decision to invest in a portfolio of collaboratives to create a statewide learning health system. These programs acknowledge that patients, clinicians, hospitals, and payers all want the same thing—high-value care.

In Michigan, the physician community sets a quality improvement agenda, which ultimately informs value-based reimbursement and pay-for-performance programs. These initiatives are pragmatic and evidence-based. Performance benchmarks and criteria for hospital and provider participation are set by the collaboratives and clinical community. This model acknowledges that effective quality improvement respects the tribal nature of medicine. Said another way, orthopedic surgeons will listen most to other orthopedic surgeons about how to improve orthopedic surgery.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×